Stabilised Protein Solutions

Patent No. EP2850099 (titled "Stabilised Protein Solutions") was filed by Novo Nordisk on Mar 15, 2013. The application was issued on Jan 18, 2017.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GLAXOSMITHKLINEOct 18, 2017BHOGAL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2850099

NOVO NORDISK
Application Number
EP13712722A
Filing Date
Mar 15, 2013
Status
Granted And Under Opposition
Dec 16, 2016
Publication Date
Jan 18, 2017